Results from a Two-Year, Phase II Clinical Trial of Resveratrol, Quercetin, and Curcumin (RQC) as a Treatment for Age-Related Macular Degeneration

Authors
Category Primary study
JournalInvest. Ophthalmol. Vis. Sci.
Year 2025
This article has no abstract
Epistemonikos ID: 071dac581609750dc84a52916b63710030c36bb8
First added on: Aug 30, 2025